MG-140 17Q21.31 microdeletion syndrome: A description of two cases
Kurston Doonanco(Alberta Children's Hospital), Shailly Jain(Alberta Children's Hospital), Cherise Klotz(Alberta Children's Hospital), Maisa Yoshimoto(University of Alberta), Judy Chernos
Cited by 0
Related Papers
FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome
|British Journal of Cancer|2007|294
Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome
|Modern Pathology|2008|278
<i>PTEN</i> genomic deletion is associated with p‐Akt and AR signalling in poorer outcome, hormone refractory prostate cancer
|The Journal of Pathology|2009|210